A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

John D. Baxter; Douglas L. Mayers; Deborah Wentworth; James D. Neaton; Marie L. Hoover; Mark A. Winters; Sharon Mannheimer; Melanie Thompson; Donald I. Abrams; Barbara Brizz; John P A Ioannidis; Thomas C. Merigan

doi:10.1097/00002030-200006160-00001

Related publications

Letter2005

Reply to Badri et al. on ‘Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis’

Thomas A Trikalinos, Ermioni T Panidou, John P A Ioannidis

Article2004

Limited benefit of antiretroviral resistance testing in treatment-experienced patients

John P A Ioannidis, Ermioni T Panidou, Thomas A Trikalinos

Article2000

Baseline HIV Type 1 Genotypic Resistance to a Newly Added Nucleoside Analog Is Predictive of Virologic Failure of the New Therapy

Kristien Van Vaerenbergh, Kristel Van Laethem, Eric Van Wijngaerden, Jean‐Claude Schmit, F Schneider, Lı́dia Ruiz, Bonaventura Clotet, Chris Verhofstede, Filip Van Wanzeele, G. M Uyldermans, P. Simons, Lieven Stuyver, P. Hermans, Christopher Evans, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article2001

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Kristien Van Vaerenbergh, Laurent Debaisieux, Nancy De Cabooter, Cathérine Declercq, K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article2021

Dual antithrombotic therapy on early clinical outcomes in patients with atrial fibrillation after percutaneous coronary intervention: a nationwide study in the era of NOAC

J Park, Jin‐Hyung Jung, Eue-Keun Choi, S W Lee, Soonil Kwon, S R Lee, Jeehoon Kang, Kyungdo Han, K W Park, Seil Oh, Professor Gregory Lip